3D Biomimetic Spine Unit Model Through the Integration of Bioprinting and Transcriptomics (CDP-SUBT)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-70
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

About this trial

The general objective of this project is to define the transcriptional profile of primary human cells derived from the nucleus pulposus (NP), annulus fibrosus (AF), and cartilaginous endplate (CEP), and to use this information as a reference to assess the biological relevance of a biomimetic spinal unit model obtained through bioprinting. By developing an in vitro model of human origin that incorporates key components of the spinal unit and applying transcriptional analyses to both native cells and their counterparts recovered from the 3D construct, the study will evaluate how accurately the bioprinted model reproduces the identity and heterogeneity of the native discal environment.

Eligibility criteria

Qualifiers

Signature of the Informed Consent for the study

Age 30-70 years (included)

Pfirrmann grade III-V

Need to undergo spinal surgery

Disqualifiers

Presence of HIV, HBC, HCV or TPHA infection

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed